Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10601108 | 0.81 | LMNA (0.32) | LMNAALDH1A1HSD17B10 | |
| SCHEMBL6632842 | 0.76 | CA12 (0.42) | ALDH1A1HSD17B10TSHRSMN1; SMN2 | |
| SCHEMBL10447228 | 0.75 | MAPT (0.38) | LMNAALDH1A1HSD17B10TSHRSMN1; SMN2 | |
| SCHEMBL483018 | 0.74 | SMN1; SMN2 (0.34) | LMNAALDH1A1HSD17B10TSHRSMN1; SMN2 | |
| SCHEMBL9236268 | 0.73 | TSHR (0.33) | LMNAALDH1A1TSHRSMN1; SMN2 | |
| SCHEMBL6630125 | 0.70 | CYP2D6 (0.32) | TSHRSMN1; SMN2 | |
| SCHEMBL6632029 | 0.70 | LMNA (0.33) | LMNAALDH1A1HSD17B10TSHRSMN1; SMN2 | |
| SCHEMBL11800128 | 0.68 | ALDH1A1 (0.35) | ALDH1A1HSD17B10TSHR | |
| SCHEMBL15303121 | 0.68 | TDP2 (0.30) | — | |
| SCHEMBL693708 | 0.68 | ALDH1A1 (0.31) | ALDH1A1HSD17B10TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040231558-A1 | Has a clear hue, high light fastness and high moisture resistance | MITSUI CHEMICALS, INC. (JP) | 2004-11-25 | — | — | US | disclosed |
| EP-1441013-A1 | WATERCOLOR INK | Mitsui Chemicals, Inc. (JP) | 2004-07-28 | — | — | EP | disclosed |